FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945697798> ?p ?o ?g. }

• W2945697798 endingPage "1718" @default.
• W2945697798 startingPage "1714" @default.
• W2945697798 abstract "This letter describes progress towards an M4 PAM preclinical candidate that resulted in the discovery of VU6005806/AZN-00016130. While the thieno[2,3-c]pyridazine core has been a consistent feature of key M4 PAMs, no work had previously been reported with respect to alternate functionality at the C3 position of the pyridazine ring. Here, we detail new chemistry and analogs that explored this region, and quickly led to VU6005806/AZN-00016130, which was profiled as a putative candidate. While, the β-amino carboxamide moiety engendered solubility limited absorption in higher species precluding advancement (or requiring extensive pharmaceutical sciences formulation), VU6005806/AZN-00016130 represents a new, high quality preclinical in vivo probe." @default.
• W2945697798 created "2019-05-29" @default.
• W2945697798 creator A5004341044 @default.
• W2945697798 creator A5005763187 @default.
• W2945697798 creator A5006299163 @default.
• W2945697798 creator A5011882836 @default.
• W2945697798 creator A5015437768 @default.
• W2945697798 creator A5021719850 @default.
• W2945697798 creator A5025743562 @default.
• W2945697798 creator A5026609125 @default.
• W2945697798 creator A5027692517 @default.
• W2945697798 creator A5032090032 @default.
• W2945697798 creator A5039213851 @default.
• W2945697798 creator A5039422454 @default.
• W2945697798 creator A5051209585 @default.
• W2945697798 creator A5058417020 @default.
• W2945697798 creator A5060483072 @default.
• W2945697798 creator A5063344947 @default.
• W2945697798 creator A5064310411 @default.
• W2945697798 creator A5070629079 @default.
• W2945697798 creator A5071066901 @default.
• W2945697798 creator A5077566010 @default.
• W2945697798 creator A5085215361 @default.
• W2945697798 date "2019-07-01" @default.
• W2945697798 modified "2023-09-27" @default.
• W2945697798 title "VU6005806/AZN-00016130, an advanced M4 positive allosteric modulator (PAM) profiled as a potential preclinical development candidate" @default.
• W2945697798 cites W1987232126 @default.
• W2945697798 cites W2010310732 @default.
• W2945697798 cites W2099379810 @default.
• W2945697798 cites W2116719688 @default.
• W2945697798 cites W2177243354 @default.
• W2945697798 cites W2320537872 @default.
• W2945697798 cites W2322053929 @default.
• W2945697798 cites W2347174806 @default.
• W2945697798 cites W2494601158 @default.
• W2945697798 cites W2557803411 @default.
• W2945697798 cites W2561733911 @default.
• W2945697798 cites W2607398836 @default.
• W2945697798 cites W2617635800 @default.
• W2945697798 cites W2736253469 @default.
• W2945697798 cites W2765221562 @default.
• W2945697798 cites W2779636705 @default.
• W2945697798 doi "https://doi.org/10.1016/j.bmcl.2019.05.026" @default.
• W2945697798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31113706" @default.
• W2945697798 hasPublicationYear "2019" @default.
• W2945697798 type Work @default.
• W2945697798 sameAs 2945697798 @default.
• W2945697798 citedByCount "6" @default.
• W2945697798 countsByYear W29456977982020 @default.
• W2945697798 countsByYear W29456977982021 @default.
• W2945697798 countsByYear W29456977982022 @default.
• W2945697798 countsByYear W29456977982023 @default.
• W2945697798 crossrefType "journal-article" @default.
• W2945697798 hasAuthorship W2945697798A5004341044 @default.
• W2945697798 hasAuthorship W2945697798A5005763187 @default.
• W2945697798 hasAuthorship W2945697798A5006299163 @default.
• W2945697798 hasAuthorship W2945697798A5011882836 @default.
• W2945697798 hasAuthorship W2945697798A5015437768 @default.
• W2945697798 hasAuthorship W2945697798A5021719850 @default.
• W2945697798 hasAuthorship W2945697798A5025743562 @default.
• W2945697798 hasAuthorship W2945697798A5026609125 @default.
• W2945697798 hasAuthorship W2945697798A5027692517 @default.
• W2945697798 hasAuthorship W2945697798A5032090032 @default.
• W2945697798 hasAuthorship W2945697798A5039213851 @default.
• W2945697798 hasAuthorship W2945697798A5039422454 @default.
• W2945697798 hasAuthorship W2945697798A5051209585 @default.
• W2945697798 hasAuthorship W2945697798A5058417020 @default.
• W2945697798 hasAuthorship W2945697798A5060483072 @default.
• W2945697798 hasAuthorship W2945697798A5063344947 @default.
• W2945697798 hasAuthorship W2945697798A5064310411 @default.
• W2945697798 hasAuthorship W2945697798A5070629079 @default.
• W2945697798 hasAuthorship W2945697798A5071066901 @default.
• W2945697798 hasAuthorship W2945697798A5077566010 @default.
• W2945697798 hasAuthorship W2945697798A5085215361 @default.
• W2945697798 hasConcept C150903083 @default.
• W2945697798 hasConcept C166342909 @default.
• W2945697798 hasConcept C181199279 @default.
• W2945697798 hasConcept C185592680 @default.
• W2945697798 hasConcept C207001950 @default.
• W2945697798 hasConcept C2777355660 @default.
• W2945697798 hasConcept C55493867 @default.
• W2945697798 hasConcept C71240020 @default.
• W2945697798 hasConcept C71924100 @default.
• W2945697798 hasConcept C74187038 @default.
• W2945697798 hasConcept C86803240 @default.
• W2945697798 hasConcept C98274493 @default.
• W2945697798 hasConceptScore W2945697798C150903083 @default.
• W2945697798 hasConceptScore W2945697798C166342909 @default.
• W2945697798 hasConceptScore W2945697798C181199279 @default.
• W2945697798 hasConceptScore W2945697798C185592680 @default.
• W2945697798 hasConceptScore W2945697798C207001950 @default.
• W2945697798 hasConceptScore W2945697798C2777355660 @default.
• W2945697798 hasConceptScore W2945697798C55493867 @default.
• W2945697798 hasConceptScore W2945697798C71240020 @default.
• W2945697798 hasConceptScore W2945697798C71924100 @default.
• W2945697798 hasConceptScore W2945697798C74187038 @default.
• W2945697798 hasConceptScore W2945697798C86803240 @default.
• W2945697798 hasConceptScore W2945697798C98274493 @default.

• next